CRISPR/Cas9-based targeting of fluorescent reporters to human iPSCs to isolate atrial and ventricular-specific cardiomyocytes
Orlando Chirikian(Cardiovascular Institute of the South), Sean M. Wu(Cardiovascular Institute of the South), Soah Lee(Sungkyunkwan University), William R. Goodyer(Cardiovascular Institute of the South), Francisco X. Galdos(Cardiovascular Institute of the South), Aimee Beck(Cardiovascular Institute of the South), Wesley L. McKeithan(MACOM (United States)), Mark Mercola(Cardiovascular Institute of the South), Joseph C. Wu(Cardiovascular Institute of the South), Beth L. Pruitt(University of California, Santa Barbara), Jan W. Buikema(Amsterdam University Medical Centers), Sharon L. Paige(Cytokinetics (United States)), Elda Dzilic(Cardiovascular Institute of the South), Vahid Serpooshan(Georgia Institute of Technology), Guang Li(Cardiovascular Institute of the South), Haodi Wu(King University), Markus Merk(University of California, Santa Barbara), Alexandre J. S. Ribeiro(Center for Drug Evaluation and Research)
Cited by 33
Related Papers
COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives
|Nature Reviews Cardiology|2020|1.5k
Wnt antagonism initiates cardiogenesis in <i>Xenopus laevis</i>
|Genes & Development|2001|482